non-linear regression curve with one-site binding equation on graphpad prism version 9 (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
non-linear regression curve with one-site binding equation on graphpad prism version 9
Non Linear Regression Curve With One Site Binding Equation On Graphpad Prism Version 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+curve+with+one-site+binding+equation+on+graphpad+prism+version+9/non+linear+regression+curve+with+one+site+binding+equation+on+graphpad+prism+version+9/pm38376808-102-10-14
Average 90 stars, based on 1 article reviews
Non Linear Regression Curve With One Site Binding Equation On Graphpad Prism Version 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+curve+with+one-site+binding+equation+on+graphpad+prism+version+9/non+linear+regression+curve+with+one+site+binding+equation+on+graphpad+prism+version+9/pm38376808-102-10-14
Average 90 stars, based on 1 article reviews
non-linear regression curve with one-site binding equation on graphpad prism version 9 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Binding Assay:Article Title: Effectiveness of [ 67 Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer. Article Snippet: Purpose To evaluate the imaging and therapeutic properties (theranostic) of 67Cu-labeled anti-human epidermal growth factor receptor II (HER2) monoclonal antibody trastuzumab against HER2-positive breast cancer (BC).. Methods We conjugated trastuzumab with p-SCN-Bn-NOTA, 3p-C-NETA-NCS, or p-SCN-Bn-DOTA, and radiolabeled with [Cu]CuCl2.. Immunoconjugate internalization was evaluated in BT-474, JIMT-1 and MCF-7 BC cells. |